Global Sleep Aid Device Market Overview:
Sleep Aid Device is known as the devices which can provide solutions to an individual’s sleeping disorder. Seeping aids device ensure the treatment and diagnosis for the sleep disturbances and disorders. The symptoms of sleep disorders normally include daytime sleepiness, irregular breathing and behaviours of abnormal sleeping and increasing movements during sleep. Sleep disorders has an very adverse effect to the human health. It can cause neural problems that can lead to the accidents, lower the productivity of work done by an individual and can also cause stress and depression. Moreover, sleep disorder can lead to some major chronic diseases like as cardiovascular diseases, obesity and diabetes Some of the key players profiled in the study are Koninklijke Philips N.V. (Netherlands), Merck & Co. (United States), Sanofi (France), DeVilbiss Healthcare LLC. (United States), Pfizer Inc. (United States), SleepMed Inc. (United States), Cadwell Laboratories Inc (United States), Compumedics Limited (Australia), Natus Medical Incorporated (United States) and GlaxoSmithKline plc (United Kingdom).
On the basis of geography, the market of Sleep Aid Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Retail Stores will boost the Sleep Aid Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disorders, the sub-segment i.e. Insomnia will boost the Sleep Aid Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing healthcare facilities,
- Surge in the demand for sleeping pills attributed to stressful modern lifestyle
- Advancement in technology related to sleeping AID device
- Adverse effects of sleep aid medication
- Patent expiration
- Technological advancements leading to better adoption
- Untapped markets in developing economies
- High cost associated with some of the sleeping AID devices
Major Market Developments:
Drive Medical Acquires DeVilbiss Healthcare, Creating a Worldwide Leader in Respiratory, Sleep and Durable Medical Products
Merck, known as MSD outside the United States and Canada, announced the first presentation of results from KEYNOTE-181, a Phase 3 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the second-line treatment of advanced or metastatic esophageal or esophagogastric junction carcinoma
Sleep Aid Device manufacturers, Sleep Aid Device and raw material suppliers, Sleep Aid Device providers, Sleep Aid Device wholesalers and retailers, Research firm, Regulatory bodies, Healthcare centres and End users
Major Objectives Focused through this Study
To define, describe, and forecast the Global Sleep Aid Device market on the basis of product [Mattress and pillows, Sleep laboratory services, Medication, Sleep apnea devices and Others] , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Sleep Aid Device market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Sleep Aid Device industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Teva Pharmaceutical Industries Ltd. (Israel), Takeda Pharmaceutical Company Limited (Japan), CareFusion Corporation (United States) and Drive Medical Ltd. (United Kingdom).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Sleep Aid Device market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.